Alkaline sphingomyelinase (alk-SMase) hydrolyses sphingomyelin (SM) to ceramide in the gut. To evaluate physiological importance of the enzyme, we generated alk-SMase knockout (KO) mice by Cre-LoxP system and studied SM digestion. Both wild type (WT) and the KO mice were fed 3 H-palmitic acid labeled SM together with milk SM by gavage.
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Introduction
Sphingomyelin (SM) is a major type of sphingolipid that is mainly present in membranes of mammalian cells and dietary products such as milk, egg, meat and fish. Our daily intake of SM is about 300 mg (1) . SM in the diet has been shown to inhibit the colonic tumorigenesis in mice treated with chemical carcinogens (2) , to promote the development of the intestinal mucosa in new born rats (3) , and to inhibit cholesterol absorption in the gut (4, 5) . Because most of these effects can be reproduced or linked to ceramide, a hydrolytic product of SM (6, 7) , it is important to study the enzymes that hydrolyze SM and generate ceramide in the gut.
More than 40 years ago Nilsson identified a type of enzyme in the intestinal mucosa that hydrolyses SM and generates ceramide at alkaline pH (8) . This enzyme was thereafter named alkaline sphingomyelinase (alk-SMase) (9) . Due to the findings of important biological effects of sphingolipids in the last two decades (10-12), we performed several studies on alk-SMase. We have purified the protein (13, 14) , cloned the gene (15, 16) , and found potential implications of the enzyme in SM digestion (17) , cell proliferation (18) , colonic inflammation (19) and cholesterol absorption (7) . We also found decreased alk-SMase activity in colonic diseases such as colon cancer and colitis (20) (21) (22) , and identified inactive abnormal splicing forms of the enzyme in human colon and liver cancer cells (23, 24) .
Besides alk-SMase, other SMases such as acid and neutral SMases were also identified in the intestinal tract (9) . Cloning study showed that alk-SMase shares no structural similarities with either acid or neutral SMase but belongs to the ectonucleotide pyrophosphatase/phosphodiesterase (NPP) family (15) . Being a novel member of this family, alk-SMase is also called NPP7. The gene encoding alk-SMase in human is Enpp7 (Gene ID: 339221) that is located at chromosome 17q25. Orthologous genes have been identified in mouse (Gene ID: 238011), rat (Gene ID: 303729) (16) , dog (Gene ID: 608627), chicken (Gene ID: 426249), monkey (Gene ID: 717416), frog (Gene ID: 100462924), and zebra fish (Gene ID: 557756). Alk-SMase has several unique properties 4 differing from other NPPs and SMases. It is expressed specifically in the intestinal mucosa in many species and additionally in human liver (25) . In the gut it is abundant in the middle part of jejunum but low in the colon. Unlike acid and neutral SMases that are rapidly inactivated by pancreatic trypsin, alk-SMase is stable and resistant to trypsin digestion (26) . As an ectoenzyme, alk-SMase is located on the surface of the mucosa and can be released into the lumen by both bile salt and pancreatic trypsin (27, 28) . The active enzyme can be transported to the colon and high activity can be detected in the feces. The enzyme can hydrolyze SM both in the intestinal lumen and mucosa. Detailed information on the enzyme has been summarized in recent review articles (26, 29) .
Based on the previous finding that SM digestion occurs mainly in the middle part of the small intestine where alk-SMase is abundant, alk-SMase is considered to be important for SM digestion (17) . However, definite proof for the role of alk-SMase has not been obtained. In the present study, by Cre-LoxP system, we created alk-SMase knockout (KO) mice. Using this animal model, we examined the SM digestion and ceramide generation in the intestinal tract in wild type (WT) and the KO mice given 
Materials and methods

Materials
Milk SM and (N- was developed by AgriSera AB (Vännäs Sweden) as described before (14) .
Genomic targeting and design
The Cre-LoxP system was used to generate alk-SMase KO mice. Targeting 
Genotype analysis and identification of alk-SMase KO mice
Both Southern blot and PCR were used in genotype analysis. Genomic DNA was extracted from mouse tail using a kit purchased from Sigma GenElute 
Animal experiment on SM digestion
Preparation of SM emulsion.
Forty µl 3 H-SM (50 Ci/mol, 0.1 mCi/ml) dissolved in ethanol was taken to dryness under nitrogen. Fifteen mg unlabeled milk SM and 16 mg bile salt mixture (Sigma B#8756) in 10 ml 0.9% sodium chloride were added followed by sonication for 5×15 seconds. The suspension was then mixed with 5 ml skim milk followed by vortex for 1 min.
Calculating with a mean molecular mass of 775 for milk SM, the SM concentration of the emulsion was 3.2 µmol per ml.
Animal treatment
After fasting for 16 h with free access to water, both WT and the KO mice were fed 0.3 ml emulsion containing 1 µmol unlabeled milk-SM and 2 µCi 3 H-SM by gavage. After 1 and 3 h, the mice were anaesthetized with Xylazine/Ketamine. Blood samples were collected by cardiac puncture. Stomach, small intestine, colon, and liver were removed.
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The small intestine was divided into three parts in equal length marked as S1, S2 and S3, which represent the proximal, middle and distal parts of small intestine, respectively. The segments were opened longitudinally, and each was rinsed in 5 ml 0.9% sodium chloride. The sodium chloride solution was then saved which represented the samples of intestinal content. Lipids in both intestinal contents and tissues were extracted as described below.
In another study, the mice were fed the same amount of the SM emulsion, and the fecal samples were collected in a metabolism cage 1 and 2 days after the gavage. The total lipids in the fecal samples were extracted.
Lipid extraction and analysis
Lipids were extracted from the intestinal contents, tissues, and feces with chloroform : methanol : water according to Bligh and Dyer (30) . The whole intestinal segment, 2 ml of the washout of the content, and a piece of the liver were used as the starting materials. 
Sphingomyelinase assay
The activities of SMases were determined as described previously (31) . 
Western blotting for alk-SMase
The Western blotting for alk-SMase in the intestinal content was performed as described before (15) . The intestinal content in the small intestine was rinsed in 20 ml of saline.
After centrifugation, the supernatant was concentrated by about 10 fold by ultrafiltration with the cut off size of the membrane being 10 KD. Fifty µl of the concentrated intestinal content were subjected to 10% SDS-PAGE and transferred to a nitrocellulose membrane.
The membrane was blotted with anti-human alk-SMase antibody (1:5000 dilution) for 2 h. and then reacted with anti-rabbit IgG antibody conjugated with horseradish peroxidase 9 (1:50000 dilution) for 1 h at room temperature. The alk-SMase bands were identified by ECL advance reagents and the emitted light was recorded on Kodak X-ray film.
Other biochemical assays
The small intestine was divided into three parts in equal length as above and was opened longitudinally. Each segment was rinsed in 5 ml 0.9% sodium chloride solution and the collected solutions represent the samples of intestinal content. The mucosa was scraped and homogenized as described previously (9) . The activities of the enzyme in both the mucosa and content were determined. The acid and alkaline phosphatase activities were analyzed using p-nitrophenylphosphate as a substrate (32) . The neutral ceramidase was assayed using 14 C-labeled C16-ceramide as a substrate (33) . Bile salt stimulated lipase (BSSL) was assayed using p-nitrophenylacetate as substrate (34) . The aminopeptidase N (APN) activity was measured by the method of Amoscato et al (35), using alanine-pnitroanilide as substrate. The protein was assayed by a DC protein assay kit obtained from Bio-Rad with bovine albumin as a standard. The activities of the enzymes analyzed in mucosal samples were adjusted to the protein levels in the samples, and those in the intestinal content were adjusted with the sample volume.
Statistical analysis
Data were expressed as means ± SEM. Statistical analysis was performed by two tails and unpaired Student t test. P < 0.05 was considered as statistically significant.
RESULTS
Generation of alk-SMase knockout mice
Screening the ES cells with the homologous recombinant gene was performed by Southern blot using the 3' probe. As shown in Fig. 2 , after Bg1II digestion, the negative ES cells yielded a 13.9 kb band corresponding to the WT allele of Enpp7, whereas the targeted ES cells with the homologous recombinant yielded an additional 8.8 kb band (Fig. 2A) . A targeted ES clone was used to produce chimeras and subsequently heterozygous mice. Heterozygous Enpp7 +/-mice were genotyped by Southern blot with "en probe" (Fig. 2B) . The WT mice showed a band of 13.9 kb whereas the heterozygous showed an additional band with 4.5 kb. After backcross, genotype of WT, heterozygous and homozygous KO mice was determined by Southern blot and later by PCR with primers indicated in Fig. 1 . A representative PCR result is shown in Fig. 2C . WT (+/+) mice gave a 732 bp band, whereas heterozygous (+/-) mice gave an additional 247 bp band and the KO (-/-) mice, only a 247 bp band (Fig. 2C) . To further confirm the successful knockout, the alk-SMase activities in the small intestinal mucosa, intestinal content and in the feces were assayed. As shown in the Fig. 3 , little activity could be identified in the KO mice in mucosa, content and feces. Western blot showed no protein band in the intestinal content of the KO mice.
Interbreeding of the heterozygous Enpp7
+/-mice yielded WT, heterozygous, and homozygous offspring at expected similar Mendelian ratios, without the appearance of embryonic lethality in the mutant mice. The sexual ratio (male: female) was approximate 1:1 either for the total offspring or the homozygous mutant. Intercrossing of the homozygous KO mice produced homozygous mutant offspring, indicating that fertility of males and females was largely unaffected. The alk-SMase KO mice grew normally without obvious abnormalities. They showed no significant changes in appearance, behavior, body weight, and the length of intestine (data not shown). Microscopic examination of one KO and one WT mouse from the same littermate did not find gross disorganization of the mucosal structure, but signs of hypertrophy of the intestinal epithelium in the KO mouse was indicated (Fig.4 and Table I ), as the widths of the villi and crypts, as well as the thickness of muscle layer under the crypts appear increased.
However, no spontaneous tumorigenesis either in the small intestine or in the colon was identified in 6 KO mice up to the age of 10 months. and not the liver of other species (16, 25) .
Activities of other Intestinal enzymes
The activities of other lipolytic enzymes including ceramidase, BSSL, alkaline phosphatase, acid phosphatase, and APN are shown in Table II . While the activities of most of the enzymes tested did not show significant alterations in the KO mice, the activities of alkaline phosphatase in KO mice were reduced in the mucosa by about half in all three segments of the small intestine compared to WT mice. However, differing from the changes of alk-SMase, no reduction of alkaline phosphatase activity in the intestinal content was identified. If anything, a slight increase of the activity was indicated towards the distal part of the small intestine.
SM digestion and ceramide generation in alk-SMase KO mice
The changes in the ability to digest SM in the KO mice were then examined. As shown in Table III , 1 h after feeding the mice 0.3 ml emulsion containing 1 µmol unlabeled milk-SM and 2 µCi of fatty acid labeled 3 H-SM, the total radioactivity in the content was found mainly in stomach and small intestine but not in the colon, whereas after 3 h, significant amounts of radioactivity was present in the colon. The total radioactivity after 1 h in the small intestinal content in the KO mice was significantly higher than in the WT mice, whereas at 3 h, the difference was most obvious in the colon indicating that the non-absorbed SM had passed the small intestine and part of the radioactivity could already have been excreted.
The total 3 H activities in the serum were also measured. In 50 µl of serum, the mean dpm for WT were 335±62 and 636±70 at 1 and 3 h, respectively, whereas those in the KO mice were 84±12 and 162±24, respectively. The serum radioactivities in the KO mice at both time points were thus about 25% of those in the WT mice.
The lipids were then extracted in both intestinal content and mucosa and analyzed by TLC. Fig 6 shows (Fig. 7B) , accompanied by a similar decrease in 3 H labeled TG in the intestinal mucosa in the KO mice (Fig. 7C ).
Three hours after gavage, the levels of The radioactivity in the fractions of FA and TG in the liver 1 and 3 h after administration is shown in Fig.8 . The levels in the KO mice were 62% and 87% lower than in the WT mice, 1 and 3 h after administration, respectively. Radioactivities in lipid classes other than TG and FA in the liver were all negligible (data not shown).
We finally examined the excreted (Fig. 9A) . On the second day, higher fecal excretion of 3 H-SM in the KO mice than in the WT mice was still observed (Fig. 9B) . However, at this time, the excreted 3 H-ceramide was equal or higher in the KO mice than in the WT mice. Such an increase in 3 Hceramide excretion was small comparing with the changes of SM, and the ratio of ceramide/SM was still significantly lower in the KO mice than in the WT ones (Fig. 9C) .
Discussion
The present study reports the successful generation of alk-SMase knockout mice and proves the importance of alk-SMase in SM digestion in the intestinal tract.
The alk-SMase KO mice were generated by Cre-LoxP system. The successful knocking out of the enzyme was clearly shown by abolishment of the enzyme activity in the intestinal mucosa, intestinal content and feces; by the partial decrease of the activity in the heterozygous animals, and by a disappearance of the protein in the gut on Western blotting. Cre-LoxP system is a newly developed method that can be used for generation either conventional or tissue specific conditional KO mice. This study was performed in the conventional alk-SMase KO mice for two reasons. First the conventional KO mice exhibited no embryonic lethality and the mice had normal global phenotypes during the period they were observed i.e. up to the age of 10 months. Second, our previous studies showed that the expression of the enzyme was highly tissue specific, and the enzyme activity as well as the expressed protein were only found in the intestinal mucosa in many 14 species studied (25) . Although the enzyme was additionally expressed in human liver and released in the bile, the liver form was not found in other species including rat, mouse, pig, rabbit, and baboon (16, 25, 36) .
Although previous studies indicated that alk-SMase is an important enzyme in SM digestion, the concept was based indirectly on the finding that hydrolysis of SM occurs mainly in the middle part of the small intestine, where alk-SMase is high (17) , and on the properties of the enzyme, in particular its dependence on certain bile salts (taurocholate or taurochenodeoxycholate), its protease resistance and its location at the brush border and in the gut lumen. Definite proof is, however, needed as the mucosa also contains acid and neutral SMases, and intestinal bacteria may be able to hydrolyze SM (37) .
The present study is the first investigation performed in alk-SMase KO mice on SM digestion. Two time points, 1 and 3 h were examined after giving the mice SM. Our results show that SM digestion mainly occurred in 1-2 h in mice, because at 3 h, much of the remaining radioactivity had reached the colon and some may already be excreted in the feces. One hour after feeding, the KO mice showed an increased accumulation of 3 H-SM associated with a decreased activity of BSSL, an enzyme previously shown to have ceramidase activity (40) . We conclude that when alk-SMase expression is knocked out, the capacity of SM digestion by acid and neutral SMase is not upregulated to a level that can take over the function of alk-SMase, and that any ceramide formed may be normally degraded by ceramidase and BSSL.
Another interesting finding in this work is the decrease of alkaline phosphatase throughout the small intestinal tract in the KO mice. Alkaline phosphatase is a brush border enzyme in the intestinal mucosa. However, the decrease did not reflect a general reduction of brush border enzyme activities in the KO mice, as the other brush border enzymes measured i.e. ceramidase and APN, were not decreased. Since the decreased alkaline phosphatase activity in the mucosa was not associated with a similar decrease in the intestinal lumen, rather a small increase in the distal part of the small intestine, further studies should focus on the membrane binding, releasing, and translocation of the enzyme in alk-SMase KO mice. Of interest is a recent finding that lysophosphatidylcholine, also a substrate for alk-SMase (15), can stimulate alkaline phosphatase release in the intestinal tract (41) . Whether the luminal levels of lysophosphatidylcholine are increased in the KO mice and thus enhancing the release of alkaline phosphatase from the mucosa is of interest for investigation. In addition, alkaline phosphatase has multiple functions including absorption of lipid, inactivation of bacterial endotoxin, and protection of the barrier function (42) , and the enzyme is structurally related to the NPP family, of which alk-SMase is a member (43) . Oral administration of alkaline phosphatase (44) and rectal administration of alk-SMase alleviate experimental colitis (19). The expression and function of the two enzymes may therefore be integrated and requires further investigation.
Finally, previous studies indicated that the hydrolysis of SM to generate ceramide may prevent tumorigenesis in the colon (26) . Marked reduction of alk-SMase activity due to the expression of abnormal splicing forms has been reported in human colon and liver cancer cells (23, 45) . In the present work with alk-SMase KO mice, we did not find spontaneous tumorigenesis either in the small intestine or colon up to 10 months of the The small intestine was divided into three parts, which represent the proximal (S1), middle (S2) and the distal parts (S3) of the small intestine, respectively. The mucosa in each segment was scraped and homogenized in 2 ml lysis buffer and the intestinal content was washed in 5 ml 0.9% saline. The alk-SMase activity in the intestinal mucosa (A) and content (B), and the acid and neutral SMase activities in intestinal mucosa (C and D) were determined as well as those in the liver. The data are means ± SEM, n = 7. * p<0.05, *** p<0.001 compared with the WT mice. given. The ratios of ceramide/SM were calculated (pane C). The results are mean + SEM from 6 mice in each group. * p<0.05, and ** p<0.01 compared with the WT mice. Tables   Table I. The width (µm) of the villi, the crypts, and the thickness of the muscle layer in the middle of the small intestine from WT and KO mice. Two female mice from the same littermate were killed. Small pieces were obtained from the middle part of the small intestine and processed for morphological analyses as 
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